Evaxion A/S EVAX Stock
Evaxion A/S Price Chart
Evaxion A/S EVAX Financial and Trading Overview
| Evaxion A/S stock price | 3.2 USD |
| Previous Close | 3.18 USD |
| Open | 3.23 USD |
| Bid | 2.34 USD x 200 |
| Ask | 4.04 USD x 200 |
| Day's Range | 3.16 - 3.28 USD |
| 52 Week Range | 2.77 - 12.15 USD |
| Volume | 33.89K USD |
| Avg. Volume | 198.65K USD |
| Market Cap | 28.87M USD |
| Beta (5Y Monthly) | 0.268 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.25 USD |
EVAX Valuation Measures
| Enterprise Value | 19.79M USD |
| Trailing P/E | N/A |
| Forward P/E | -213.33334 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.8537908 |
| Price/Book (mrq) | 2.79965 |
| Enterprise Value/Revenue | 2.642 |
| Enterprise Value/EBITDA | -2.377 |
Trading Information
Evaxion A/S Stock Price History
| Beta (5Y Monthly) | 0.268 |
| 52-Week Change | -53.95% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 12.15 USD |
| 52 Week Low | 2.77 USD |
| 50-Day Moving Average | 3.12 USD |
| 200-Day Moving Average | 3.69 USD |
EVAX Share Statistics
| Avg. Volume (3 month) | 198.65K USD |
| Avg. Daily Volume (10-Days) | 37K USD |
| Shares Outstanding | 9.02M |
| Float | 5.68M |
| Short Ratio | 0.1 |
| % Held by Insiders | 16.14% |
| % Held by Institutions | 9.31% |
| Shares Short | 53.78K |
| Short % of Float | 0.70% |
| Short % of Shares Outstanding | 0.59% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -115.53% |
| Operating Margin (ttm) | -116.019% |
| Gross Margin | 100.00% |
| EBITDA Margin | -111.14% |
Management Effectiveness
| Return on Assets (ttm) | -25.97% |
| Return on Equity (ttm) | -109.85% |
Income Statement
| Revenue (ttm) | 7.49M USD |
| Revenue Per Share (ttm) | 0.94 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 7.49M USD |
| EBITDA | -8326000 USD |
| Net Income Avi to Common (ttm) | -8655000 USD |
| Diluted EPS (ttm) | -0.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14M USD |
| Total Cash Per Share (mrq) | 1.68 USD |
| Total Debt (mrq) | 7.11M USD |
| Total Debt/Equity (mrq) | 74.55 USD |
| Current Ratio (mrq) | 5.062 |
| Book Value Per Share (mrq) | 1.143 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7164000 USD |
| Levered Free Cash Flow (ttm) | -5487625 USD |
Profile of Evaxion A/S
| Country | United States |
| State | N/A |
| City | Horsholm |
| Address | Dr. Neergaards Vej |
| ZIP | 2970 |
| Phone | 45 53 53 18 50 |
| Website | https://evaxion.ai |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 46 |
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin and soft tissue infections with S. aureus bacteria; EVX-B2 to target multi-component prophylactic vaccine against gonorrhea bacteria; EVX-B3 to target bacterial pathogen associated with repeated infections; and EVX-V1, a multi-component prophylactic vaccine candidate for cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
Q&A For Evaxion A/S Stock
What is a current EVAX stock price?
Evaxion A/S EVAX stock price today per share is 3.2 USD.
How to purchase Evaxion A/S stock?
You can buy EVAX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evaxion A/S?
The stock symbol or ticker of Evaxion A/S is EVAX.
Which industry does the Evaxion A/S company belong to?
The Evaxion A/S industry is Biotechnology.
How many shares does Evaxion A/S have in circulation?
The max supply of Evaxion A/S shares is 9.02M.
What is Evaxion A/S Price to Earnings Ratio (PE Ratio)?
Evaxion A/S PE Ratio is now.
What was Evaxion A/S earnings per share over the trailing 12 months (TTM)?
Evaxion A/S EPS is -1 USD over the trailing 12 months.
Which sector does the Evaxion A/S company belong to?
The Evaxion A/S sector is Healthcare.
Evaxion A/S EVAX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27190.86 USD — |
+1.19
|
6.86B USD — | 27112.24 USD — | 27353.68 USD — | — - | 6.86B USD — |
|
US Tech Health Care
IXHC
US
|
1302.61 USD — |
-0.29
|
— — | 1298.55 USD — | 1311.62 USD — | — - | — — |
- {{ link.label }} {{link}}
